Physician profile
Kellie S Toth
NPI 1316029630
$15,915.52
in general payments reported to CMS, 2019-2025
31 companies · $3,235 in 2025
The $3,235 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,689 · 2022: $2,803 · 2023: $3,453 · 2024: $4,736 · 2025: $3,235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,056.29 |
| Education | $367.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,169.38 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $1,835.89 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $1,749.49 | 2021-2025 | Ilumya, Winlevi, Absorica Ld |
| Janssen Biotech, INC. | $1,702.39 | 2021-2025 | Tremfya, Simponi Aria, Stelara |
| Ucb, INC. | $1,265.48 | 2021-2025 | Bimzelx, Cimzia |
| Dermavant Sciences, INC. | $954.41 | 2023-2024 | Vtama |
| Genzyme Corporation | $719.37 | 2021-2025 | |
| Pfizer INC. | $706.84 | 2021-2025 | |
| Incyte Corporation | $706.53 | 2022-2025 | Opzelura, Opzelura |
| Lilly USA, LLC | $591.02 | 2021-2025 | Ebglyss, Olumiant, Taltz |
| Regeneron Healthcare Solutions, INC. | $489.63 | 2021-2025 | Dupixent, Libtayo |
| Leo Pharma INC. | $305.50 | 2021-2025 | Adbry, Anzupgo |
| E.R. Squibb & Sons, L.L.C. | $296.92 | 2022-2025 | Sotyktu |
| Galderma Laboratories, L.P. | $290.52 | 2021-2025 | Nemluvio, Aklief |
| Arcutis Biotherapeutics, INC. | $208.40 | 2023-2025 | Zoryve |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $183.29 | 2022-2025 | |
| Amgen INC. | $129.19 | 2021-2025 | Otezla, Otezla |
| Organon LLC | $85.67 | 2023-2025 | Vtama, Hadlima |
| Almirall LLC | $84.84 | 2022-2025 | Klisyri |
| Mallinckrodt Hospital Products INC. | $76.15 | 2024 | Acthar |
| Journey Medical Corporation | $65.37 | 2022-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $61.24 | 2021-2024 | Cabtreo, Arazlo |
| Sanofi-Aventis U.S. LLC | $54.95 | 2024 | |
| Biofrontera INC. | $39.56 | 2021-2025 | Xepi, Bf-Rhodoled, Ameluz |
| Fresenius Kabi USA, LLC | $33.80 | 2023-2024 | Idacio |
| Dermira, INC. | $26.16 | 2021 | |
| Botanix Sb INC | $20.43 | 2025 | Sofdra |
| Kerecis Limited | $19.16 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.33 | 2022 | |
| Medimetriks Pharmaceuticals, INC. | $14.51 | 2024 | Clindacin Etz |
| Bioventus LLC | $14.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellie Toth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.